Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons
Abstract
Authors
V Strand I McInnes H Thom M Hunger N Lopes K Gandhi SM Jugl